I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Phase I study on the safety, pharmacokinetic profile, and e..:
Ikeda, Masafumi
;
Shiina, Shuichiro
;
Nakachi, Kohei
...
Investigational New Drugs. 32 (2014) 5 - p. 928-936 , 2014
Link:
https://doi.org/10.1007/s10637-014-0109-2
RT Journal T1
Phase I study on the safety, pharmacokinetic profile, and efficacy of the combination of TSU-68, an oral antiangiogenic agent, and S-1 in patients with advanced hepatocellular carcinoma
UL https://suche.suub.uni-bremen.de/peid=cr-10.1007_s10637-014-0109-2&Exemplar=1&LAN=DE A1 Ikeda, Masafumi A1 Shiina, Shuichiro A1 Nakachi, Kohei A1 Mitsunaga, Shuichi A1 Shimizu, Satoshi A1 Kojima, Yasushi A1 Ueno, Hideki A1 Morizane, Chigusa A1 Kondo, Shunsuke A1 Sakamoto, Yasunari A1 Asaoka, Yoshinari A1 Tateishi, Ryosuke A1 Koike, Kazuhiko A1 Arioka, Hitoshi A1 Okusaka, Takuji PB Springer Science and Business Media LLC YR 2014 SN 0167-6997 SN 1573-0646 JF Investigational New Drugs VO 32 IS 5 SP 928 OP 936 LK http://dx.doi.org/https://doi.org/10.1007/s10637-014-0109-2 DO https://doi.org/10.1007/s10637-014-0109-2 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)